Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Information Builders Presents the Organizational Intelligence Webcast Series

Industry Visionaries Showcase Brilliant Ways to Use Data and Analytics, Based on the Company’s Newly Launched BookNew York, NY – November 8, 2016 – Information Builders , a leader in business intelligence  (BI) and analytics, information integrity, and integration solutions, today announced the Organizational Intelligence Webcast Series , comprised of four events that will feature insight from

Valmet enters into a strategic partnership for power and process industry automation in Australia, New Zealand and South East Asia

Valmet Oyj's trade press release on November 8, 2016 at 10:00 a.m. EET Valmet has signed a strategic value-added reseller (VAR) agreement for power and process industry automation with Globetech Pty Ltd based in Australia and Globetech Asia based in Vietnam. The agreement covers Australia, New Zealand, Laos, Cambodia, Myanmar, Singapore and possibly other South East Asian countries later on. "By having an experienced automation partner by our side, we will be able to better serve our customers in the power and process industries. Valmet's system reliability and upgradability are

Atea Denmark signs contract with JN Data A/S

Atea Denmark signs contract with JN Data A/S for services related to full operation of end-user platforms. The contract runs for 5 years with option for renewal of additional 2 years with an estimated annual contract value of NOK 100-125 million. Atea will provide services related to full client operation and full virtual client operation including related application and image maintenance for desktops/laptops/virtual desktops, print operation, mobile device management and consultancy through this agreement. For further information, please contact:Steinar Sønsteby, CEO Atea ASA,

US patent imminent for Seamless’ SEQR payment solution

Stockholm Nasdaq-listed Seamless has obtained a Notice of Allowance (patent application no. 14/347,742) from the United States Patent and Trademark Office (USPTO) for its SEQR mobile payment solution. This implies that USPTO intends to announce the approval of the patent within three months following the payment of all fees.The company’s patent representative has confirmed that all patent fees have been paid and the patent is thus expected to be approved shortly, thereby providing important protection for SEQR in the US. The patent application relates to the central technology used in SEQR

Swedish ICA stores – October 2016 sales figures

Sales in the Swedish ICA stores decreased by 1.3% in October 2016 compared with the corresponding month last year. Sales in like-for-like stores decreased by 1.7%.+-----------+-------+----------+-------------+------+----------+-------------+| | October | January – October 2016 || | 2016 | |+-----------+-------+----------+-------------+------+----------+-------------+|Store | SEKm|Change all| Change| SEKm|Change all| Change||sales, | |

KONE's share capital increases through the subscription of shares with 2013 and 2014 option rights

KONE Corporation, stock exchange release, November 8, 2016 at 09.45 a.m. EET KONE's share capital increases through the subscription of shares with 2013 and 2014 option rights A total of 273,650 new KONE class B shares have been subscribed for with 2013 option rights and a total of 9,373 new KONE class B shares with 2014 option rights. The amount of subscribed KONE class B shares is 283,023 in total. The corresponding EUR 35,377.88 increase in KONE Corporation's share capital has been entered into the Finnish Trade Register on November 8, 2016. Trading of the new shares will start on

NeuroVive’s recruitment of Michele Tavecchio strengthens its research organization

Lund, Sweden, November 8, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that the company has recruited Michele Tavecchio, PhD, as senior scientist.In his new role, Dr. Tavecchio will be leading R&D activities related to NeuroVive's discovery programs, working closely with CSO Eskil Elmér, CMO Magnus Hansson, and the core research team of scientists at NeuroVive. Dr. Tavecchio holds a PhD in Cancer Pharmacology from the Mario Negri Institute for Pharmacological Research in Milan and has authored over 20

Nuevolution to present at upcoming investor conferences

Stockholm, 8 November 2016. Nuevolution AB (publ) (NUE.ST), a leading small molecule drug discovery biotech company, today announced that it will be presenting at investor conferences in Gothenburg and London on 14 and 18 November 2016, respectively. PRESENTATION AND WEBCAST ON 14 NOVEMBER, GOTHENBURG At Aktiespararna’s Stora Aktiedagen 2016 in Gothenburg, Alex Haahr Gouliaev, CEO of Nuevolution AB (publ), will provide an overview of the Company’s business during the live presentation on Monday 14 November 2016, at 16:00-16:30 CET. This event is webcast on http://www.aktiespararna.se/

INVISIO establishes U.S. subsidiary

Stockholm, November 08, 2016  INVISIO has established a wholly owned subsidiary in the USA to increase its presence in the US market. The establishment is part of the company's strategic objective to build a strong presence in key markets. The company has also begun recruiting staff for sales and marketing of the company's systems for communication and hearing protection. The subsidiary, INVISIO Communications Inc, is to support existing customers and partners, increasing the customer base and develop and maintain business networks. INVISIO already has valuable customers in the US

Acetium capsule prevents the exposure to carcinogenic acetaldehyde in patients with atrophy of the stomach mucosa

Biohit Oyj Press Release November 8, 2016 at 09:30 am local time (EET) New scientific evidence on Acetium capsule has been obtained. A collaborative study with Uppsala University shows that Acetium capsule prevents acetaldehyde exposure in patients suffering from the atrophy of the stomach mucosa (atrophic gastritis) caused by Helicobacter pylori infection. The scientific report has recently been published in Scandinavian Journal of Gastroenterology. Acetaldehyde associated with alcohol consumption is a group 1 human carcinogen implicated in the pathogenesis of gastric cancer.

Jays open pre-order for celebratory q-JAYS Anniversary edition earphones

Award-winning Swedish audio product developer Jays AB (publ) announced earlier this year the release of a limited anniversary edition of the well renowned q-JAYS Reference earphones. As of today, q-JAYS Anniversary edition is available for pre-order in JAYS Online Store and expected to start shipping by December 1st 2016.q-JAYS Anniversary edition has been developed to celebrate Jays’ 10-year anniversary and is precision made by CNC and laser cutting, fine-polished to a unique metal look in an all stainless steel housing. A brand new, high-quality, twisted white cable set will also

Redwood Pharma AB (publ) to present at Aktiespararna conference in Örebro on November 19, 2016

On Saturday, November 19 Redwood Pharma AB will present at the conference ”Inspirationsträff för tjejer - Våga spara i aktier!” at the City Konferenscenter, Klostergatan 23 in Örebro between 09.30 and 16.00 hrsOn Saturday, November 19 Aktiespararna is hosting a meeting to inspire women to invest in equities. Redwood Pharma’s product candidate RP101 is being designed to help this target segment who suffer from moderate to severe Dry Eye Disease. CEO Martin Vidaeus will present Redwood Pharma and its RP101 project and will be open to meet with interested investors and answer questions. For

Vestas - Interim financial report, third quarter 2016

Summary: In the third quarter of 2016, Vestas generated revenue of EUR 2,903m – an increase of 37 percent compared to the year-earlier period. EBIT before special items increased by EUR 201m to EUR 433m. The EBIT margin before special items was 14.9 percent compared to 10.9 percent in the third quarter of 2015 and the free cash flow amounted to EUR 155m compared to EUR 158m in the third quarter of 2015.The intake of firm and unconditional wind turbine orders amounted to 1,769 MW in the third quarter of 2016. The value of the wind turbine order backlog amounted to EUR 7.2bn at 30 September

New gas spring configurator online

A new gas spring configurator has been released online, where users can design and download complete gas spring assemblies in the 3D CAD format of their choice. The main advantage of the configurator is that it gives engineers complete freedom to design a custom gas spring into their application from a single, easy to use interface. Once downloaded, the models can be imported into the designers CAD software, or even used as abasis for quotation. Lesjöfors broad production capacity and wide range of standard components gives users almost limitless configurations to make use of.

Etrion to Release Third Quarter 2016 Results on November 10, 2016

November 8, 2016, Miami, Florida – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, will release its third quarter 2016 results before market open on Thursday, November 10, 2016. Earnings Call A conference call/webcast to present the Company’s third quarter results will be held on Thursday, November 10, 2016, at 10:00 a.m. Eastern Standard Time (EST) / 4:00 p.m. Central European Time (CET).  Dial-in details:  North America: +1-647-788-4919 / Toll Free: +1-877-291-4570 / Sweden Toll Free: 02-079-4343 Webcast:  A

Kongsberg Automotive reports Q3 2016 results

Q3 2016 report and Capital Markets Day 2016 resentation follow attachedThird quarter 2016 highlights include: · Revenues were MEUR 228.0 in the third quarter, MEUR 1.4 below the third quarter last year excluding negative translation currency effects of MEUR 4.0. · EBIT was MEUR -5.0 (-2.2%) in the third quarter, versus an EBIT of MEUR 10.4 (4.5%) in the third quarter last year. · The third quarter EBIT was impacted by one-off items of MEUR 10.8. In addition, we incurred MEUR 0.8 of restructuring costs. · Reclassification of commercial currency loss from financial items to

Strong profit development for the third quarter

1 July–30 September 2016 · Net sales amounted to SEK 2,327 M (2,128) · Operating profit was SEK 228 M (180). Operating margin amounted to 10 per cent (8) · Profit after financial items was SEK 159 M (93) · Profit for the period after tax was SEK 125 M (75) · Cash flow before financing was SEK -32 M (152) · Earnings per share were SEK 1.15 (0.70) · Return on capital employed amounted to 15 per cent (7) · The number of housing units sold in the period was 965 (1,402). The number of production starts of housing units in the period was 897 (1,389) 1 January–30

Resurs Holding Interim Report January—September 2016

1 July—30 September 2016* · Lending to the public rose 43% to SEK 20,593 million, up slightly more than 5% compared with Q2 2016, resulting in annualised growth of approximately 20% · Operating income increased by 29% to SEK 717 million · Operating profit increased 37% to SEK 302 million, and 35% to SEK 337 million excl. nonrecurring costs · Earnings per share rose 29% to SEK 1.12, and 32% to SEK 1.30 excl. nonrecurring costs · C/I before credit losses (excl. Insurance) was 44.6% (45.6), and 39.4% (39.9) excl. nonrecurring costs · The credit loss ratio was 1.9% (2.1)

Moberg Pharma AB Interim report January - September 2016

SIGNIFICANT GROWTH IN SALES AND PROFITABILITYPERIOD (JAN-SEPT 2016)* · Revenue MSEK 244.9 (231.9) · EBITDA MSEK 65.9 (42.4) · EBITDA for Commercial Operations MSEK 76.0 (59.9) · Operating profit (EBIT) MSEK 55.1 (34.1) · Net profit after tax MSEK 35.1 (25.1) · Earnings per share SEK 2.45 (1.76) · Operating cash flow per share SEK -1.64 (pos: 1.99) THIRD QUARTER (JUL-SEPT 2016) · Revenue MSEK 104.1 (66.6) · EBITDA MSEK 29.0 (13.8) · EBITDA for Commercial Operations MSEK 32.6 (18.1) · Operating profit (EBIT) MSEK 23.4 (10.9) · Net profit after tax

Nexam Chemical Holding AB (publ) Interim Financial Report 1 January – 30 September 2016

Progress within PET-foamThird quarter at a glance Operational: · Scale-up of NEXAMITE® at contract manufacturer. Multiplied production capacity reduces manufacturing cost. Financials: · Net sales for the third quarter totaled SEK 1,113,000 (4,197,000*). *Including sales of SEK 2,471,000 regarding products outside the company’s strategic focus. · The operating loss for the third quarter SEK –5,785,000 (-2,625,000). · In comparison to the beginning of the year, cash and cash equivalents amounted to SEK 143,350,000 (36,305,000). · Cash flow from operating activities

Statement by the Board of Directors of Haldex in relation to the public cash offer by Knorr-Bremse

BACKGROUND This statement (the “Statement”) is made by the Board of Directors (the “Board”) of Haldex Aktiebolag (“Haldex” or the “Company”) pursuant to Section II.19 of Nasdaq Stockholm’s Takeover Rules (the “Takeover Rules”), following the withdrawal by ZF Friedrichshafen (“ZF”) of its offer to the Haldex shareholders on 5 October 2016. As previously communicated, the Chairman of Haldex, Göran Carlson, has sold his shares in Haldex, representing approximately 5.7% of the total number of shares and votes in Haldex, to ZF. As a result, Göran Carlson has not participated in the Board’s

Finnair Traffic Performance in October 2016

Finnair Plc         Stock Exchange Release         8 November 2016 at 09:00 am EET Cargo demand conditions have improved; number of passengers at last year’s level In October, Finnair's overall capacity measured in Available Seat Kilometres grew by 3.9 per cent and traffic measured in Revenue Passenger Kilometres grew by 2.1 per cent year‐on‐year. The passenger load factor declined by 1.4 percentage points to 79.9 per cent. In October, Finnair began gradual transition to its winter season traffic programme. The capacity in Finnair’s largest traffic area, Asia, grew by 8.9 per cent

There are no items matching the current filter
There are no more items matching the current filter
Back to top